Clinical Trial Update: Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ Study [Phase 4]

View source ↗

Summary

ULTRAZ, a Phase 4 trial evaluating leukocyte trafficking after Zeposia (ozanimod) treatment in ulcerative colitis, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Zeposia (ozanimod hydrochloride)

Snippet

Sponsor: Geert D'Haens | Conditions: Ulcerative Colitis | Phase 4 | Status: WITHDRAWN